Developers believe the study is the first-in-human demonstration for a drug that could safely prevent its development.
19hon MSN
Cancer's malignant remote control: How tumors reprogram liver fat metabolism to disarm immune cells
In their quest to understand how cancers take root, grow and spread, scientists have for the past half-century explored the ...
Bacteria in lung tumors may boost the activation of innate immune cells in the presence of a common vitamin metabolite, ...
Researchers discovered a possible way cancer cells hide from the immune system: they build a thick, sugar-rich coating around ...
Researchers discovered lymph node-like immune hubs inside skull bone marrow that appear to act as rapid-response centers for ...
Cancer immunotherapy has reshaped the oncology landscape over the past decade, but the next phase of development is ...
ELI-002 7P showed robust mKRAS-specific T-cell responses in 99% of evaluable pancreatic cancer patients in the phase 2 trial. The vaccine targets seven common KRAS mutations, prevalent in a ...
21hon MSN
Scientists in France pinpoint why STING pathway hasn't been harnessed for cancer therapy yet
Deep within the cellular landscape, a quiet failure was taking place, impeding a potentially successful form of cancer ...
Jim Day was told he had six months to live after a stage 4 melanoma diagnosis. A cancer-fighting virus helped shrink his ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results